Cronos Group Inc. Common Share (CRON) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cronos Group Inc. Common Share, updated every trading day.
Health Care · Medicinal Chemicals and Botanical Products
Cronos Group Inc. Common Share (CRON) is a Health Care company in Medicinal Chemicals and Botanical Products, worth $1.2B. It trades at $3.35, down 0.89% today, at 17.6 times earnings. Its overall quality score is 81 out of 100, ranked against the whole US market. 1 analysts' average target of $4.98 implies +48.7% from today's price. Kronos AI's 30-day forecast is −8.3% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $4.98 |
| Low – high | $4.98 – $4.98 |
| Analysts | 1 |
| Upside to average | +48.7% |
Kronos AI 30-day forecast
| Expected close | $3.10 (−8.3%) |
| Likely range | −11.3% … −6.6% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 67 |
| Solvency | 92 |
| Growth | 83 |
| Overall | 81 |
| P/E | 17.6 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator